Inflammatory bowel disease Flashcards
1
Q
IBD - overview
A
- CD, UC, CD 2x as common as UC
- Incidence 5/100,000/yr
- Cause unknown but recognised genetic disposition
2
Q
IBD - UC vs UC
A
UC
- Involves colon only
- Proctitis (rectum) is most common or may extend continuously up to involve the entire colon (pancolitis)
- Terminal ileum may be affected by ‘backwash ileitis’
CD
- May affect any part of GI tract, but terminal ileum + proximal colon are commonest sites of involvement
- Unlike UC, bowel involvement is non-continuous (‘skip’ lesions)
3
Q
IBD - symptoms
A
- Anorexia, weight loss, lethargy
- Abdominal cramps
- Diarrhoea +/- blood/mucus
- Urgency and tenesmus (proctitis)
- Fever
4
Q
IBD - signs
A
GI
- Aphthous oral ulcers
- Abdominal tenderness
- Abdominal distension (UC>CD)
- RIF mass (CD)
- Perianal disease (CD) - i.e. abscess, sinus, fistula, skin tags, fissure, stricture
Non-GI signs and associations (5 + 5 = 10)
1. Fever
2. Finger clubbing
3. Anaemia
4. Poor growth, delayed puberty
5. Nutritional deficiencies (e.g. vitamin B12)
___
6. Skin = erythema nodosum (red tender lumps on shins), pyoderma gangrenosum (deep ulcers, usually on legs)
7. Joints = arthritis, ankylosing spondylitis
8. Eyes = iritis, conjunctivitis, episcleritis
9. Sclerosing cholangitis
10. Renal stones
5
Q
IBD - complications
A
- ‘Toxic’ colon dilatation (UC>CD)
- GI perforation or strictures; massive GI haemorrhage
- Pseudopolyps (apparent ‘polyps’) resulting from inflammation
- Colon carcinoma (UC = 50% risk after 10-20y of disease)
- Fistula involving bowel only or bowel + skin/vagina/bladder (CD); abscesses (CD)
Check Toronto for differences between UC and CD in clinical presentation - ?
6
Q
IBD - ix
A
- Bloods (10) = FBE, ESR (raised), CRP (raised), UEC, LFTs, albumin, blood cultures, serum iron (decreased), vitamin B12, folate (decreased)
- Serum serological markers (ASCA better for CD, p-ANCA better for UC)
- Stool MCS = checking for infectious colitis
- Endoscopy + biopsy = colonoscopy to determine extent and pattern of abnormal mucosa + intestinal biopsy
- UC histology = crypt abscesses, mucosal inflammation only, goblet cell depletion
- CD = crypt abscesses, granulomas, transmural inflammation - Barium enema for both CD and UC - but role is fairly limited
7
Q
IBD - mx
A
- Supportive tx = if severe, .e.g bowel rest, IV hydration, PN
- Drug tx (initial)
* UC
- 5-aminosalicylic acid (ASA) orally (+ mesalazine if proctitis)
- If no response, use prednisolone orally + taper over 6-8 weeks to cease (rectally if proctitis; budesonide or hydrocortisone PR are alternatives)
* CD
- Prednisolone orally, taper over 6-8 weeks to cease
* Both (severe)
- Use IV hydrocortisone or IV methylprednisolone - Maintenance therapy
* UC
- 5-ASA (+ mesalazine PR if used previously)
- If frequent relapses, add azathioprine or mercaptopurine
- If refractory to tx, add infliximab
* CD
- Azathioprine or mercaptopurine
- If ineffective, consider methotrexate + folic acid
- If refractory to tx, use infliximab or adalimumab - Dietary supplementation to minimise poor growth and correct specific nutritional deficiencies - e.g. vitamin and mineral supplements. Involve a paediatric dietitian
- Surgery
- UC = total colectomy and ileostomy, and later pouch creation and anal anastomosis; cures UC. 10-20% complication rate, e.g. pouchitis
- CD = local surgical resection for severe localised disease, e.g. strictures, fistula. However, there is a high re-operation rate as inflammation recurrence is universal
8
Q
IBD - prognosis
A
- Marked by relapse and remission
- Can still have good QoL
- Poor prognostic factors = extensive disease, frequent remissions, young age at dx